Introducing Glucema®

Non-invasive Diabetes

Testing and Monitoring

Introducing Glucema®

The first and only point-of-care saliva test for diabetes monitoring

Salient features of Glucema test

Easy to use non-invasive test

5-10 minutes to read from a drop of saliva

Test once every 7-14 days

Provides quick estimate of recent average glucose levels to monitor treatment


Advantages Over Current Tests

Short-term index provides more rapid indication of therapy efficacy than 3 to 4-month period reflected by HbA1c

Unlike other short-term parameters such as fructosamine or 1,5-AG, the non-invasive, saliva-based Glucema POC test does not require a blood sample or a clinical laboratory

For more information about Glucema, please click here

One drop of saliva can now monitor and test for Type 2 diabetes.